The Transaction constitutes a merger pursuant to Article 3(1)(a) of the Merger
Regulation. Following the Transaction, the Novo Group will hold in aggregate 22% of the total share capital and 61% of the total voting rights of the combined group and therefore be the controlling shareholder.